Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder

This publication has 25 references indexed in Scilit:

• Atomoxetine Pharmacokinetics in Children and Adolescents with Attention Deficit Hyperactivity Disorder
  Journal of Child and Adolescent Psychopharmacology, 2003
• Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults
  Drug Safety, 2003
• Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study
  American Journal of Psychiatry, 2002
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
  Neuropsychopharmacology, 2002
• Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics
  The Journal of Clinical Pharmacology, 2002
• Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
  Pediatrics, 2001
• An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity Disorder
  Journal of Child and Adolescent Psychopharmacology, 2001
• An Open-Label Trial of Tomoxetine in Pediatric Attention Deficit Hyperactivity Disorder
  Journal of Child and Adolescent Psychopharmacology, 2001
• A Randomized Trial of Single- and Two-Dose Ivermectin versus Thiabendazole for Treatment of Strongyloidiasis
  The Journal of Infectious Diseases, 1994
• Alterations in K+-evoked release of 3H-norepinephrine and contractile responses in urethral and bladder tissues induced by norepinephrine reuptake inhibition
  Life Sciences, 1993